Next Quarterly Earnings
No earnings planned
Currently, no future quarterly earnings are announced for this company.
Merus
Merus N.V. is a Netherlands-based clinical-stage biopharmaceutical company focused on developing bispecific and multispecific antibody therapies for cancer. Using its Biclonics platform, Merus researches novel oncology drug candidates for hard-to-treat tumors.
Frequently asked questions
How do I add the Merus earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Company Information
Name
Merus
Country
🇳🇱
More Financial Information